Skip to main content
. Author manuscript; available in PMC: 2021 Apr 15.
Published in final edited form as: Int J Cardiol. 2020 Jan 9;305:56–62. doi: 10.1016/j.ijcard.2020.01.012

Figure 1:

Figure 1:

Correlation between clinical parameters and GDF-15. (A) GDF-15 was significantly elevated in Patients with APC Fontan as compared to LT or ECC Fontan. (B) Duration of APC Fontan moderately correlated positively with GDF-15 levels. (C) Biomarker levels were compared between control cohort, Fontan patients without events and Fontan patients with events. In Fontan patients with events, and without events, GDF-15 levels were increased as compared to control. *p≤0.05, ****p≤0.0001